You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › February › 04
AI
17 months ago
Palantir surged 24% on robust fourth-quarter results and guidance.
Palantir soars 23% to record high as AI powers strong earnings and guidance ○
Palantir surged more than 23% on robust fourth-quarter results and guidance.
Ark Invest's Cathie Wood says the most underappreciated application of AI is health care ○
"I think the most underappreciated application of AI is health care. Health care is responsible for an incredible amount of storage," Wood said.
Palantir soars 23% to record high as AI powers strong earnings and guidance ○
Palantir surged more than 23% on robust fourth-quarter results and guidance.
Palantir soars 24% to record high as AI powers strong earnings and guidance ○
Palantir surged more than 24% on robust fourth-quarter results and guidance.
Palantir soars 25% to record high as AI powers strong earnings and guidance ○
Palantir surged more than 25% on robust fourth-quarter results and guidance.
Palantir soars more than 23% as AI powers strong earnings and guidance ○
Palantir surged more than 23% in premarket trading on robust fourth-quarter results and guidance.
Your phone buzzes with a news alert. But what if AI wrote it – and it’s not true? | Archie Bland ○
The BBC said Apple Intelligence’s weirdly wrong output sullied its reputation. Apple eventually paused the tool – but its reaction was deeply worrying
My first mistake at the Guardian came, agonisingl…
EU pushes forward with enforcing AI Act despite Trump warnings ○
found
a story from Financial Times ✅ › Financial Times
Brussels set to issue guidance on banned uses of AI, even as US president threatens retaliation over treatment of Big Tech
Hundreds of thousands of women to be screened for breast cancer using AI technology called EDITH in a bid to cut waiting lists ○
Almost 700,000 patients will be asked to participate in the project which is hoped will 'spark a revolution in cancer care' and transform future breast cancer screening.